Total Funding
36
42
Total FundingPost-IPO Debt raised
Growth Score
-1 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
121761
Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.
- Marcel Konrad: CFOPast Role: Santen Pharmaceutical, Chief Financial Officer
- Ken d' Entremont: Founder, President, and CEOPast Role: Medexus, President & CEO
About the Company
Medexus Pharma is a pharmaceutical company that offers products for rare diseases. They provide healthcare products that address a variety of diseases, including rheumatology, auto-immune diseases, pediatrics, and specialty oncology. They offer healthcare products to healthcare professionals and patients.
